Institute of Inflammation and Ageing World leading discovery and translational science in inflammation and ageing
News Latest research finds hypertension drug could be repurposed to delay ageing Latest research has found that rilmenidine, a drug used to treat hypertension, can be used to slow ageing and extend lifespan.
News Inflammation and Ageing Research Fellow receives £1.2M Competitive MRC Career Development Fellowship
News Latest study uncovers findings of periodontal therapy in reducing rheumatoid arthritis disease activity
20 December 2021 Drug could more effectively treat patients hospitalised with COVID-19 pneumonia, research finds A proof-of-concept trial has identified a drug that may offer benefit some patients hospitalised with COVID-19 pneumonia.
04 November 2021 Study exposes risks and benefits of virtual consultations with doctors So-called 'telemedicine' is less diagnostically accurate than in-person consultations and could increase health inequalities and barriers to accessing appropriate care.
03 November 2021 New drug treatment regimen shows promise for patients with lupus New drug treatment regimen, using belimumab soon after rituximab, reduced a disease-related autoantibody and severe disease flares in lupus patients.
27 October 2021 Specific cell population plays a key role in the affect arthritis has on the body and the pain patients feel, study finds Scientists at the University of Birmingham have led a study which has identified a new specific population of cells that plays a key role in the affect arthritis has on the body and the subsequent pain felt by patients.
22 October 2021 Artificial Intelligence project aims to improve standards and development of AI systems A new project has been launched in partnership with the University of Birmingham aiming to address racial and ethical health inequalities using artificial intelligence.
11 October 2021 Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.